Discontinuation report ILARIS
| Report ID | 93588 |
| Drug Identification Number | 02344939 |
| Brand name | ILARIS |
| Common or Proper name | ILARIS 150MG 1X1 VIAL |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CANAKINUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1 X 1 |
| ATC code | L04AC |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-09-11 |
| Remaining supply date | 2019-09-11 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Replaced with ILARIS 150MG 1X1 LIQ VIAL - DIN #02460351 - Product Code 736120 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-09-12 | English | Compare |
| v3 | 2019-09-11 | French | Compare |
| v2 | 2019-09-11 | English | Compare |
| v1 | 2019-09-11 | English | Compare |
Showing 1 to 4 of 4